Fredua-Agyeman, M;
Stapleton, P;
Basit, AW;
Beezer, AE;
Gaisford, S;
(2017)
In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study.
International Journal of Pharmaceutics
, 517
(1-2)
pp. 96-103.
10.1016/j.ijpharm.2016.12.005.
Preview |
Text
Gaisford_IJP-D-16-01970 R1 revised document.pdf - Accepted Version Download (256kB) | Preview |
Abstract
The aim of the study was to investigate the influence of some commercial probiotics on the growth of Clostridium difficile using isothermal microcalorimetry, a technique which can monitor the real time growth of bacteria. Commercial probiotic strains and products, Lactobacillus acidophilus LA-5(®), Bifidobacterium lactis BB-12(®), Probio 7(®) and Symprove™ were co-cultured with C. difficile in Brain Heart Infusion (BHI) broth supplemented with 0.1% (w/v) l-cysteine hydrochloride and 0.1% (w/v) sodium taurocholate and monitored in the microcalorimeter. Pseudomonas aeruginosa NCIMB 8628 was also co-cultured with C. difficile and studied. The results indicated inhibition of C. difficile by the probiotics. The inhibition of C. difficile was shown to be pH-dependent using neutralized and unmodified cell free supernatant (CFS) produced by the probiotic strains. However, concentrated CFS of the probiotics also inhibited the intestinal pathogen in a non pH-dependent manner, likely due to specific antimicrobial substances produced. The results also indicated that C. difficile growth was greatly influenced by the presence of sodium taurocholate and by the pH of the medium. A medium pH of between 6.45 and 6.9 demonstrated maximum growth of the organism in the microcalorimeter.
| Type: | Article |
|---|---|
| Title: | In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study |
| Location: | Netherlands |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ijpharm.2016.12.005 |
| Publisher version: | http://dx.doi.org/10.1016/j.ijpharm.2016.12.005 |
| Language: | English |
| Additional information: | Copyright © 2016. This manuscript version is published under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International licence (CC BY-NC-ND 4.0). This licence allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Further details about CC BY licences are available at http://creativecommons.org/licenses/by/4.0. Access may be initially restricted by the publisher. |
| Keywords: | Clostridium difficile, Co-culture, Inhibition, Isothermal microcalorimetry, Probiotics |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharma and Bio Chemistry UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmaceutics |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1533238 |
Loading...
Loading...Loading...| 1. |  United States | 28 |
| 2. |  China | 13 |
| 3. |  United Kingdom | 8 |
| 4. |  Korea, Republic of | 7 |
| 5. |  France | 2 |
| 6. |  Nigeria | 1 |
| 7. |  South Africa | 1 |
| 8. |  Indonesia | 1 |
| 9. |  Poland | 1 |
| 10. |  Switzerland | 1 |
Archive Staff Only
 |
View Item |
